[
  {
    "title": "上海莱士(002252.SZ)：第三季度净利5.43亿元，同比增长11.73%",
    "href": "http://stock.jrj.com.cn/2022/10/28231037096223.shtml",
    "datetime": "2022-10-28 23:10:19",
    "code": "002252"
  },
  {
    "title": "徐俊出任上海莱士总经理：加盟公司10年 去年薪酬460万元",
    "href": "http://stock.jrj.com.cn/2022/10/20111137069258.shtml",
    "datetime": "2022-10-20 11:11:36",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：聘请JUN XU(徐俊)出任总经理",
    "href": "http://stock.jrj.com.cn/2022/10/19172937067379.shtml",
    "datetime": "2022-10-19 17:29:10",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：股东莱士中国减持量过半 累计被动减持0.25%股份",
    "href": "http://stock.jrj.com.cn/2022/09/08162736983440.shtml",
    "datetime": "2022-09-08 16:27:42",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)上半年净利10.61亿元，同比增长16.55%",
    "href": "http://stock.jrj.com.cn/2022/08/29230236949731.shtml",
    "datetime": "2022-08-29 23:02:54",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国拟被动减持3240万股",
    "href": "http://stock.jrj.com.cn/2022/07/26165436843945.shtml",
    "datetime": "2022-07-26 16:54:47",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：被动减持数过半 莱士中国已减持585股",
    "href": "http://stock.jrj.com.cn/2022/07/25200536841148.shtml",
    "datetime": "2022-07-25 20:05:31",
    "code": "002252"
  },
  {
    "title": "上海莱士副总经理JUN XU增持41万股 耗资237.76万 2022年第一季度公司净利5.48亿",
    "href": "http://stock.jrj.com.cn/2022/07/20223136830104.shtml",
    "datetime": "2022-07-20 22:31:12",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：获副总经理徐俊增持41万股",
    "href": "http://stock.jrj.com.cn/2022/07/20193536829576.shtml",
    "datetime": "2022-07-20 19:35:22",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国被动减持股份达1.3%",
    "href": "http://stock.jrj.com.cn/2022/07/08115436793890.shtml",
    "datetime": "2022-07-08 11:54:59",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：中信银行通过司法划转方式取得5.06%股份",
    "href": "http://stock.jrj.com.cn/2022/07/01120036774686.shtml",
    "datetime": "2022-07-01 12:00:56",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚累计被动减持5.06%股份",
    "href": "http://stock.jrj.com.cn/2022/06/29200936769059.shtml",
    "datetime": "2022-06-29 20:09:02",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：2021年年度权益分派10派0.28元 股权登记日7月6日",
    "href": "http://stock.jrj.com.cn/2022/06/29200336769076.shtml",
    "datetime": "2022-06-29 20:03:11",
    "code": "002252"
  },
  {
    "title": "上海莱士股东莱士中国被动减持3547.9万股 2021年公司净利12.95亿",
    "href": "http://stock.jrj.com.cn/2022/06/17223236739695.shtml",
    "datetime": "2022-06-17 22:32:00",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国已通过集中竞价被动减持3547.9001万股",
    "href": "http://stock.jrj.com.cn/2022/06/17204536739414.shtml",
    "datetime": "2022-06-17 20:45:10",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国拟被动减持不超999股",
    "href": "http://stock.jrj.com.cn/2022/06/17201136739266.shtml",
    "datetime": "2022-06-17 20:11:12",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：减持数过半 科瑞天诚已被动减持1417股",
    "href": "http://stock.jrj.com.cn/2022/05/25170536677913.shtml",
    "datetime": "2022-05-25 17:05:44",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：一季度净利升28.63%至5.48亿元",
    "href": "http://stock.jrj.com.cn/2022/04/29183736506187.shtml",
    "datetime": "2022-04-29 18:37:53",
    "code": "002252"
  },
  {
    "title": "上海莱士2021年净利12.95亿同比下滑2.21% 董事长陈杰薪酬667.92万",
    "href": "http://stock.jrj.com.cn/2022/04/28101036490924.shtml",
    "datetime": "2022-04-28 10:10:37",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)2021年度扣非净利润升3.96%至13.69亿元 拟10派0.28元",
    "href": "http://stock.jrj.com.cn/2022/04/27235236487785.shtml",
    "datetime": "2022-04-27 23:52:31",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚及其一致行动人累计被动减持54.55万股",
    "href": "http://stock.jrj.com.cn/2022/04/11211336308313.shtml",
    "datetime": "2022-04-11 21:13:16",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚完成被动减持3849.72万股",
    "href": "http://stock.jrj.com.cn/2022/04/11210836308261.shtml",
    "datetime": "2022-04-11 21:08:47",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：被动减持时间过半 莱士中国已被动减持0.52%股份",
    "href": "http://stock.jrj.com.cn/2022/03/17180134840063.shtml",
    "datetime": "2022-03-17 18:01:50",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：拟终止莱士南方生物制品生产基地项目",
    "href": "http://stock.jrj.com.cn/2022/03/15194034830525.shtml",
    "datetime": "2022-03-15 19:40:54",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：减持期过半 科瑞天诚已被动减持0.56%股份",
    "href": "http://stock.jrj.com.cn/2022/01/11204134147532.shtml",
    "datetime": "2022-01-11 20:41:45",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞金鼎被动减持2160.90万股",
    "href": "http://stock.jrj.com.cn/2022/01/11203934147524.shtml",
    "datetime": "2022-01-11 20:39:59",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：减持数过半 莱士中国已被动减持0.27%股份",
    "href": "http://stock.jrj.com.cn/2022/01/05204334126325.shtml",
    "datetime": "2022-01-05 20:43:34",
    "code": "002252"
  },
  {
    "title": "上海莱士子公司静注人免疫球蛋白恢复生产",
    "href": "http://stock.jrj.com.cn/2021/12/27213834072606.shtml",
    "datetime": "2021-12-27 21:38:03",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：全资子公司静注人免疫球蛋白恢复生产",
    "href": "http://stock.jrj.com.cn/2021/12/27201734072307.shtml",
    "datetime": "2021-12-27 20:17:06",
    "code": "002252"
  },
  {
    "title": "上海莱士股东科瑞金鼎被动减持48.32万股 第三季度公司净利4.86亿",
    "href": "http://stock.jrj.com.cn/2021/12/20215034036861.shtml",
    "datetime": "2021-12-20 21:50:46",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚完成被动减持48.32万股",
    "href": "http://stock.jrj.com.cn/2021/12/20201034036038.shtml",
    "datetime": "2021-12-20 20:10:32",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：子公司再次通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/12/15193834020718.shtml",
    "datetime": "2021-12-15 19:38:03",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：获得人凝血酶药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2021/12/15193734020716.shtml",
    "datetime": "2021-12-15 19:37:16",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚投资控股已被动减持2.09%的股份",
    "href": "http://stock.jrj.com.cn/2021/12/02201533956757.shtml",
    "datetime": "2021-12-02 20:15:29",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国拟被动减持不超3548万股",
    "href": "http://stock.jrj.com.cn/2021/11/25164833919219.shtml",
    "datetime": "2021-11-25 16:48:11",
    "code": "002252"
  },
  {
    "title": "上海莱士股东科瑞天诚被动减持6357.33万股 第三季度公司净利4.86亿",
    "href": "http://stock.jrj.com.cn/2021/11/25052933916048.shtml",
    "datetime": "2021-11-25 05:29:08",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚累计被动减持6357.328万股",
    "href": "http://stock.jrj.com.cn/2021/11/24195133915434.shtml",
    "datetime": "2021-11-24 19:51:53",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚一致行动人拟被动减持不超48.32万股",
    "href": "http://stock.jrj.com.cn/2021/11/24194733915420.shtml",
    "datetime": "2021-11-24 19:47:07",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国已通过大宗交易被动减持1024万股",
    "href": "http://stock.jrj.com.cn/2021/11/03191033809388.shtml",
    "datetime": "2021-11-03 19:10:38",
    "code": "002252"
  },
  {
    "title": "上海莱士股东将被动减持不超1024万股公司股份 上半年公司净利9.1亿",
    "href": "http://stock.jrj.com.cn/2021/10/13215833687169.shtml",
    "datetime": "2021-10-13 21:58:52",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国拟被动减持不超1024万股",
    "href": "http://stock.jrj.com.cn/2021/10/13184833686091.shtml",
    "datetime": "2021-10-13 18:48:24",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：郑州莱士获得静注人免疫球蛋白(PH4)的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2021/09/22191233499914.shtml",
    "datetime": "2021-09-22 19:12:28",
    "code": "002252"
  },
  {
    "title": "上海莱士变成无实控人状态：实控人3年以来多次被强制平仓 强平股份占总股本29%",
    "href": "http://stock.jrj.com.cn/2021/09/09104733408475.shtml",
    "datetime": "2021-09-09 10:47:47",
    "code": "002252"
  },
  {
    "title": "上海莱士：控股股东、实控人变更为无",
    "href": "http://stock.jrj.com.cn/2021/09/08220633406162.shtml",
    "datetime": "2021-09-08 22:06:24",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：深圳莱士被动减持211万股",
    "href": "http://stock.jrj.com.cn/2021/09/08203833405815.shtml",
    "datetime": "2021-09-08 20:38:06",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚被动减持1729.2万股",
    "href": "http://stock.jrj.com.cn/2021/09/08203633405811.shtml",
    "datetime": "2021-09-08 20:36:44",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚将被动减持不超3850万股",
    "href": "http://stock.jrj.com.cn/2021/09/08203433405805.shtml",
    "datetime": "2021-09-08 20:34:40",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：控股股东、实控人变更为无",
    "href": "http://stock.jrj.com.cn/2021/09/08203133405790.shtml",
    "datetime": "2021-09-08 20:31:31",
    "code": "002252"
  },
  {
    "title": "上海莱士收关注函 上交所问股东被动减持后对公司影响",
    "href": "http://stock.jrj.com.cn/2021/08/26161833324405.shtml",
    "datetime": "2021-08-26 16:18:00",
    "code": "002252"
  },
  {
    "title": "上海莱士收关注函：要求说明公司控制权是否（拟）发生变更",
    "href": "http://stock.jrj.com.cn/2021/08/25170933317134.shtml",
    "datetime": "2021-08-25 17:09:07",
    "code": "002252"
  },
  {
    "title": "上海莱士半年盈利9.1亿增三成 并购扩张资产增31倍负债率仅3%",
    "href": "http://stock.jrj.com.cn/2021/08/25072833314105.shtml",
    "datetime": "2021-08-25 07:28:11",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚被动减持477.3577万股",
    "href": "http://stock.jrj.com.cn/2021/08/24221133312205.shtml",
    "datetime": "2021-08-24 22:11:03",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国被动减持4800万股",
    "href": "http://stock.jrj.com.cn/2021/08/24220833312197.shtml",
    "datetime": "2021-08-24 22:08:40",
    "code": "002252"
  },
  {
    "title": "上海莱士2021年半年度净利9.1亿元 同比净利增加30.67%",
    "href": "http://stock.jrj.com.cn/2021/08/20121733286268.shtml",
    "datetime": "2021-08-20 12:17:22",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)上半年净利升30.67%至9.10亿元",
    "href": "http://stock.jrj.com.cn/2021/08/19171533281085.shtml",
    "datetime": "2021-08-19 17:15:21",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚及一致行动人累计被动减持6.72亿股",
    "href": "http://stock.jrj.com.cn/2021/08/13200633250397.shtml",
    "datetime": "2021-08-13 20:06:28",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：人凝血酶原复合物获批上市",
    "href": "http://stock.jrj.com.cn/2021/07/16161933107782.shtml",
    "datetime": "2021-07-16 16:19:38",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：财务负责人刘峥辞职 仍担任副总经理、董秘职务",
    "href": "http://stock.jrj.com.cn/2021/07/09163233070039.shtml",
    "datetime": "2021-07-09 16:32:04",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：下属沂源县莱士获得单采血浆许可证",
    "href": "http://stock.jrj.com.cn/2021/06/29160733015917.shtml",
    "datetime": "2021-06-29 16:07:20",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)2020年度权益分派10派0.25元 股权登记日为7月1日",
    "href": "http://stock.jrj.com.cn/2021/06/24174632990449.shtml",
    "datetime": "2021-06-24 17:46:54",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司及郑州莱士将继续积极推进郑州莱士静注人免疫球蛋白工艺变更事项",
    "href": "http://stock.jrj.com.cn/2021/06/23194032984576.shtml",
    "datetime": "2021-06-23 19:40:42",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司暂无定增或并购计划",
    "href": "http://stock.jrj.com.cn/2021/06/23193732984542.shtml",
    "datetime": "2021-06-23 19:37:04",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司级分生产出的组分中间体主要用于人血白蛋白和静注人免疫球蛋白产品的生产",
    "href": "http://stock.jrj.com.cn/2021/06/23192832984491.shtml",
    "datetime": "2021-06-23 19:28:51",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司暂无相关股票回购或股权激励计划",
    "href": "http://stock.jrj.com.cn/2021/06/23192832984494.shtml",
    "datetime": "2021-06-23 19:28:20",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚被动减持5.0969万股",
    "href": "http://stock.jrj.com.cn/2021/06/21164932969986.shtml",
    "datetime": "2021-06-21 16:49:54",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国原质押给湘财证券的1075万股公司股份因逾期未还款被法院强制执行",
    "href": "http://stock.jrj.com.cn/2021/06/21164732969973.shtml",
    "datetime": "2021-06-21 16:47:31",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司将持续完善网站建设工作",
    "href": "http://stock.jrj.com.cn/2021/06/11224032914272.shtml",
    "datetime": "2021-06-11 22:40:52",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司生产经营情况良好",
    "href": "http://stock.jrj.com.cn/2021/06/11214332914045.shtml",
    "datetime": "2021-06-11 21:43:44",
    "code": "002252"
  },
  {
    "title": "上海莱士：目前公司采浆工作稳步推进",
    "href": "http://stock.jrj.com.cn/2021/06/08065932890578.shtml",
    "datetime": "2021-06-08 06:59:18",
    "code": "002252"
  },
  {
    "title": "上海莱士：目前 无国家相关血液制品的储备政策",
    "href": "http://stock.jrj.com.cn/2021/06/02163232863488.shtml",
    "datetime": "2021-06-02 16:32:17",
    "code": "002252"
  },
  {
    "title": "上海莱士：截至目前 郑州莱士各项设施改造完成 已通过药品监管部门现场检查",
    "href": "http://stock.jrj.com.cn/2021/06/02162032863416.shtml",
    "datetime": "2021-06-02 16:20:25",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司将积极推动与基立福在多个领域的合作",
    "href": "http://stock.jrj.com.cn/2021/06/01183732858338.shtml",
    "datetime": "2021-06-01 18:37:14",
    "code": "002252"
  },
  {
    "title": "上海莱士：预计2021年与Biotest Pharma GmbH发生的协议金额约为 1155 万欧元",
    "href": "http://stock.jrj.com.cn/2021/06/01183632858337.shtml",
    "datetime": "2021-06-01 18:36:55",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：郑州莱士预计最快于2021年6月底前递交相关补充资料",
    "href": "http://stock.jrj.com.cn/2021/05/31171532850757.shtml",
    "datetime": "2021-05-31 17:15:09",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司2020年3-12月GDS营业收入506,915.40万元、净利润145,592.22万元",
    "href": "http://stock.jrj.com.cn/2021/05/24204832812469.shtml",
    "datetime": "2021-05-24 20:48:33",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：今年4月21日以来科瑞天诚已被动减持2649.7092万股",
    "href": "http://stock.jrj.com.cn/2021/05/21221032795404.shtml",
    "datetime": "2021-05-21 22:10:45",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司血液制品毛利率与行业内规模类似公司的差异不大",
    "href": "http://stock.jrj.com.cn/2021/05/14222032757707.shtml",
    "datetime": "2021-05-14 22:20:20",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司财务费用降低主要是2020年存款利息收入大幅增加所致",
    "href": "http://stock.jrj.com.cn/2021/05/14203432757231.shtml",
    "datetime": "2021-05-14 20:34:40",
    "code": "002252"
  },
  {
    "title": "上海莱士：目前公司已与基立福签订了质量协议、独家代理协议等",
    "href": "http://stock.jrj.com.cn/2021/05/14201632757187.shtml",
    "datetime": "2021-05-14 20:16:40",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司在生产过程中采用病毒检测方法（核酸扩增法）即为NAT检测技术",
    "href": "http://stock.jrj.com.cn/2021/05/14201532757186.shtml",
    "datetime": "2021-05-14 20:15:57",
    "code": "002252"
  },
  {
    "title": "上海莱士：目前公司已与瑞金、中山和华山三大医院开展了业务合作",
    "href": "http://stock.jrj.com.cn/2021/05/11200332737322.shtml",
    "datetime": "2021-05-11 20:03:20",
    "code": "002252"
  },
  {
    "title": "上海莱士2021年第一季度净利增长37.14% 利息收入增加",
    "href": "http://stock.jrj.com.cn/2021/04/24091632434590.shtml",
    "datetime": "2021-04-24 09:16:11",
    "code": "002252"
  },
  {
    "title": "上海莱士去年净利13亿 商誉计提减值4.6亿净值52.6亿",
    "href": "http://stock.jrj.com.cn/2021/04/23105032429021.shtml",
    "datetime": "2021-04-23 10:50:00",
    "code": "002252"
  },
  {
    "title": "上海莱士2020年净利13.24亿增长117.75% 董事长陈杰薪酬568.41万",
    "href": "http://stock.jrj.com.cn/2021/04/23091532428272.shtml",
    "datetime": "2021-04-23 09:15:30",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)2020年净利升117.75%至13.24亿元 拟10派0.25元",
    "href": "http://stock.jrj.com.cn/2021/04/22232232426320.shtml",
    "datetime": "2021-04-22 23:22:04",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)一季度净利润4.26亿元 同比增长37.14%",
    "href": "http://stock.jrj.com.cn/2021/04/22231732426301.shtml",
    "datetime": "2021-04-22 23:17:53",
    "code": "002252"
  },
  {
    "title": "上海莱士：控股股东所持公司股份仍存在质押、冻结的情况",
    "href": "http://stock.jrj.com.cn/2021/03/31161632256310.shtml",
    "datetime": "2021-03-31 16:16:58",
    "code": "002252"
  },
  {
    "title": "上海莱士：重组人血清白蛋白产品到目前为止未对人血白蛋白市场产生重大影响",
    "href": "http://stock.jrj.com.cn/2021/03/31161632256311.shtml",
    "datetime": "2021-03-31 16:16:48",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司2020年度商誉减值测试工作尚在进行中",
    "href": "http://stock.jrj.com.cn/2021/03/29171932242032.shtml",
    "datetime": "2021-03-29 17:19:13",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司和郑州莱士仍在积极推进郑州莱士生产基地搬迁的战略规划",
    "href": "http://stock.jrj.com.cn/2021/03/29171732242014.shtml",
    "datetime": "2021-03-29 17:17:07",
    "code": "002252"
  },
  {
    "title": "上海莱士：目前 公司相关产品的价格较为稳定",
    "href": "http://stock.jrj.com.cn/2021/03/12184432122735.shtml",
    "datetime": "2021-03-12 18:44:34",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司库存情况处于合理水平",
    "href": "http://stock.jrj.com.cn/2021/03/10164132103923.shtml",
    "datetime": "2021-03-10 16:41:27",
    "code": "002252"
  },
  {
    "title": "上海莱士：目前 公司相关产品的价格较为稳定",
    "href": "http://stock.jrj.com.cn/2021/03/03160432063813.shtml",
    "datetime": "2021-03-03 16:04:12",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：控股股东及一致行动人被动减持6.781%股份",
    "href": "http://stock.jrj.com.cn/2021/03/02205032059305.shtml",
    "datetime": "2021-03-02 20:50:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：由于公司集团内部研发项目的分配调整 对静注乙型肝炎人免疫球蛋白事项申报提出申请撤回",
    "href": "http://stock.jrj.com.cn/2021/02/26162732033281.shtml",
    "datetime": "2021-02-26 16:27:23",
    "code": "002252"
  },
  {
    "title": "上海莱士股东股份冻结信披违规 董事长陈杰遭通报批评",
    "href": "http://stock.jrj.com.cn/2021/02/24182932019906.shtml",
    "datetime": "2021-02-24 18:29:00",
    "code": "002252"
  },
  {
    "title": "上海莱士2020年预计净利12.77亿-14.59亿增长110%-140% 血液制品销售收入增长",
    "href": "http://stock.jrj.com.cn/2021/01/30155731815096.shtml",
    "datetime": "2021-01-30 15:57:04",
    "code": "002252"
  },
  {
    "title": "上海莱士：2019年公司全年采浆量近1,230吨",
    "href": "http://stock.jrj.com.cn/2021/01/07163831648439.shtml",
    "datetime": "2021-01-07 16:38:46",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)拟与基立福国际签署独家代理协议",
    "href": "http://stock.jrj.com.cn/2021/01/05205131636512.shtml",
    "datetime": "2021-01-05 20:51:11",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：莱士中国10月28日以来被动减持比例达1.11%",
    "href": "http://stock.jrj.com.cn/2020/12/30132431604202.shtml",
    "datetime": "2020-12-30 13:24:38",
    "code": "002252"
  },
  {
    "title": "上海莱士及董事长等收5警示函 6成股本遭冻结信披违规",
    "href": "http://stock.jrj.com.cn/2020/12/18164331519126.shtml",
    "datetime": "2020-12-18 16:43:00",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：科瑞天诚投资控股已被动减持13502.6333万股",
    "href": "http://stock.jrj.com.cn/2020/12/16170931502989.shtml",
    "datetime": "2020-12-16 17:09:20",
    "code": "002252"
  },
  {
    "title": "上海莱士：2020年8月 郑州莱士管理层预计现有车间复产时间将延后至2021年6月 延迟约6个月左右",
    "href": "http://stock.jrj.com.cn/2020/12/08200131442607.shtml",
    "datetime": "2020-12-08 20:01:37",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司参与风险投资2020年1-9月实现收益 143.85 万元",
    "href": "http://stock.jrj.com.cn/2020/12/08161631440435.shtml",
    "datetime": "2020-12-08 16:16:49",
    "code": "002252"
  },
  {
    "title": "上海莱士(002252.SZ)：收到上海证监局警示函",
    "href": "http://stock.jrj.com.cn/2020/12/08144231439515.shtml",
    "datetime": "2020-12-08 14:42:04",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司将与GDS、基立福在多个领域进行战略合作",
    "href": "http://stock.jrj.com.cn/2020/11/27162131361018.shtml",
    "datetime": "2020-11-27 16:21:58",
    "code": "002252"
  },
  {
    "title": "上海莱士2020年前三季度净利10.96亿增长80.8% 投资收益增长",
    "href": "http://stock.jrj.com.cn/2020/10/29144231157446.shtml",
    "datetime": "2020-10-29 14:42:29",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司将与基立福在多个领域进行战略合作",
    "href": "http://stock.jrj.com.cn/2020/10/19161231084079.shtml",
    "datetime": "2020-10-19 16:12:21",
    "code": "002252"
  },
  {
    "title": "上海莱士：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/15081131057079.shtml",
    "datetime": "2020-10-15 08:11:24",
    "code": "002252"
  },
  {
    "title": "上海莱士2020年前三季度净利10.3亿-10.91亿 坏账损失减少",
    "href": "http://stock.jrj.com.cn/2020/10/14190231053027.shtml",
    "datetime": "2020-10-14 19:02:27",
    "code": "002252"
  },
  {
    "title": "上海莱士2020年上半年净利6.97亿增长68.70% 加大销售力度",
    "href": "http://stock.jrj.com.cn/2020/08/27112930602878.shtml",
    "datetime": "2020-08-27 11:29:41",
    "code": "002252"
  },
  {
    "title": "券商、信托踩雷 如今银行也上诉追债！这家血制品龙头股权质押危机不断 两大股东股质比超90%",
    "href": "http://stock.jrj.com.cn/2020/08/07085030447602.shtml",
    "datetime": "2020-08-07 08:50:00",
    "code": "002252"
  },
  {
    "title": "安徽通报药品检查 上海莱士美诺华丰原药业子公司整改",
    "href": "http://stock.jrj.com.cn/2020/08/03184630414738.shtml",
    "datetime": "2020-08-03 18:46:00",
    "code": "002252"
  },
  {
    "title": "[上海莱士]百尺竿头,上海莱士再登2019年度中国医药工业百强系列榜!",
    "href": "http://stock.jrj.com.cn/2020/07/23000030324435.shtml",
    "datetime": "2020-07-23 00:00:00",
    "code": "002252"
  },
  {
    "title": "百济神州定增20.8亿美元创纪录 上海莱士上半年业绩预增逾60% | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/07/14190030240564.shtml",
    "datetime": "2020-07-14 19:00:16",
    "code": "002252"
  },
  {
    "title": "上海莱士：上半年净利润预计同比增长68%-80%",
    "href": "http://stock.jrj.com.cn/2020/07/13214830228161.shtml",
    "datetime": "2020-07-13 21:48:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/13211030227936.shtml",
    "datetime": "2020-07-13 21:10:00",
    "code": "002252"
  },
  {
    "title": "上海莱士2020年上半年预计净利6.95亿元至7.45亿元 主营业务发展平稳",
    "href": "http://stock.jrj.com.cn/2020/07/13205430227835.shtml",
    "datetime": "2020-07-13 20:54:02",
    "code": "002252"
  },
  {
    "title": "上海莱士上半年净利润预增68%-80%",
    "href": "http://stock.jrj.com.cn/2020/07/13182430226965.shtml",
    "datetime": "2020-07-13 18:24:32",
    "code": "002252"
  },
  {
    "title": "实控人陷债务泥潭 昔日“血王”上海莱士遭遇扩张危机",
    "href": "http://stock.jrj.com.cn/2020/07/07082830162028.shtml",
    "datetime": "2020-07-07 08:28:36",
    "code": "002252"
  },
  {
    "title": "上海莱士控股股东以股抵债被动减持7000万股 占总股本1.04%",
    "href": "http://stock.jrj.com.cn/2020/07/02121530120718.shtml",
    "datetime": "2020-07-02 12:15:49",
    "code": "002252"
  },
  {
    "title": "[上海莱士]“天马奖”榜单揭晓, 上海莱士再获“中小板最佳董事会奖”",
    "href": "http://stock.jrj.com.cn/2020/06/23000029999835.shtml",
    "datetime": "2020-06-23 00:00:00",
    "code": "002252"
  },
  {
    "title": "蹊跷！回归“正业”的上海莱士业绩高增 实控人却被动减持1020万股",
    "href": "http://stock.jrj.com.cn/2020/06/08073029868741.shtml",
    "datetime": "2020-06-08 07:30:00",
    "code": "002252"
  },
  {
    "title": "上海莱士第一季度盈利3.11亿同比增长41.97% 投资收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/05/01185429440891.shtml",
    "datetime": "2020-05-01 18:54:07",
    "code": "002252"
  },
  {
    "title": "上海莱士一季报业绩增长超四成",
    "href": "http://stock.jrj.com.cn/2020/04/28100029401932.shtml",
    "datetime": "2020-04-28 10:00:10",
    "code": "002252"
  },
  {
    "title": "上海莱士：一季度净利润同比增长41.97%",
    "href": "http://stock.jrj.com.cn/2020/04/28084729401127.shtml",
    "datetime": "2020-04-28 08:47:00",
    "code": "002252"
  },
  {
    "title": "上海莱士2019年净利6.08亿 较上年同期扭亏为盈",
    "href": "http://stock.jrj.com.cn/2020/04/26223829379405.shtml",
    "datetime": "2020-04-26 22:38:10",
    "code": "002252"
  },
  {
    "title": "上海莱士股东科瑞天诚被动减持3679万股",
    "href": "http://stock.jrj.com.cn/2020/03/20214529072042.shtml",
    "datetime": "2020-03-20 21:45:49",
    "code": "002252"
  },
  {
    "title": "国内新冠肺炎疫情蔓延扩散势头得到基本遏制 上海莱士收到终止应急征用通知",
    "href": "http://stock.jrj.com.cn/2020/03/16205529035209.shtml",
    "datetime": "2020-03-16 20:55:43",
    "code": "002252"
  },
  {
    "title": "上海莱士：收到终止应急征用通知",
    "href": "http://stock.jrj.com.cn/2020/03/16205229035186.shtml",
    "datetime": "2020-03-16 20:52:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：重大资产重组收到上海市商务委员会《企业境外投资证书》",
    "href": "http://stock.jrj.com.cn/2020/03/10202228993641.shtml",
    "datetime": "2020-03-10 20:22:02",
    "code": "002252"
  },
  {
    "title": "放弃“炒股”聚焦主业 上海莱士去年盈利6.2亿元",
    "href": "http://stock.jrj.com.cn/2020/02/27081328904015.shtml",
    "datetime": "2020-02-27 08:13:00",
    "code": "002252"
  },
  {
    "title": "上海莱士2019年度盈利6.20亿 血液制品行业景气度高",
    "href": "http://stock.jrj.com.cn/2020/02/26182028898408.shtml",
    "datetime": "2020-02-26 18:20:50",
    "code": "002252"
  },
  {
    "title": "上海莱士业绩快报：2019年净利6.2亿元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2020/02/26161028897713.shtml",
    "datetime": "2020-02-26 16:10:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：2019年净利6.2亿元 同比大幅扭亏",
    "href": "http://stock.jrj.com.cn/2020/02/26155128897628.shtml",
    "datetime": "2020-02-26 15:51:48",
    "code": "002252"
  },
  {
    "title": "上海莱士向湖北孝感捐赠168万元药品",
    "href": "http://stock.jrj.com.cn/2020/02/16114928834471.shtml",
    "datetime": "2020-02-16 11:49:00",
    "code": "002252"
  },
  {
    "title": "上海莱士捐赠的第二批驰援药品抵达湖北",
    "href": "http://stock.jrj.com.cn/2020/02/15142928833228.shtml",
    "datetime": "2020-02-15 14:29:00",
    "code": "002252"
  },
  {
    "title": "MSCI中国A股在岸指数新增6家成分股 京沪高铁、金山办公、上海莱士市值前三",
    "href": "http://stock.jrj.com.cn/2020/02/13064928818737.shtml",
    "datetime": "2020-02-13 06:49:00",
    "code": "002252"
  },
  {
    "title": "[上海莱士]再次援手,上海莱士向湖北孝感捐赠168万元药品",
    "href": "http://stock.jrj.com.cn/2020/02/13000029297608.shtml",
    "datetime": "2020-02-13 00:00:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：收到《生产能力应急征用通知》",
    "href": "http://stock.jrj.com.cn/2020/02/04175228768017.shtml",
    "datetime": "2020-02-04 17:52:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：上海经信委紧急征用公司的医疗防护用品、药品及生产能力",
    "href": "http://stock.jrj.com.cn/2020/02/04170928767806.shtml",
    "datetime": "2020-02-04 17:09:45",
    "code": "002252"
  },
  {
    "title": "上海莱士：收到上海市经信委生产能力应急征用通知",
    "href": "http://stock.jrj.com.cn/2020/02/04164928767685.shtml",
    "datetime": "2020-02-04 16:49:19",
    "code": "002252"
  },
  {
    "title": "上海莱士：上海经信委紧急征用公司的医疗防护用品、药品、器械及生产能力",
    "href": "http://stock.jrj.com.cn/2020/02/04164728767684.shtml",
    "datetime": "2020-02-04 16:47:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：向武汉捐赠药品、现金共800余万元",
    "href": "http://stock.jrj.com.cn/2020/02/03094628751409.shtml",
    "datetime": "2020-02-03 09:46:00",
    "code": "002252"
  },
  {
    "title": "[上海莱士]上海莱士向武汉捐赠药品、现金共800余万元",
    "href": "http://stock.jrj.com.cn/2020/02/01000028816955.shtml",
    "datetime": "2020-02-01 00:00:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/23075028725478.shtml",
    "datetime": "2020-01-23 07:50:01",
    "code": "002252"
  },
  {
    "title": "上海莱士：预计2019年净利5.94亿-7.26亿元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2020/01/22160428721094.shtml",
    "datetime": "2020-01-22 16:04:49",
    "code": "002252"
  },
  {
    "title": "上海莱士：2019年预盈5.94亿至7.26亿 同比大幅扭亏",
    "href": "http://stock.jrj.com.cn/2020/01/22160328721091.shtml",
    "datetime": "2020-01-22 16:03:00",
    "code": "002252"
  },
  {
    "title": "[科华生物]科华生物首台Polaris c2000正式落地上海莱士",
    "href": "http://stock.jrj.com.cn/2020/01/06000028629969.shtml",
    "datetime": "2020-01-06 00:00:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：重大资产重组获证监会核准批复",
    "href": "http://stock.jrj.com.cn/2019/12/25203828586778.shtml",
    "datetime": "2019-12-25 20:38:46",
    "code": "002252"
  },
  {
    "title": "上海莱士：重大资产重组事项获证监会核准批复",
    "href": "http://stock.jrj.com.cn/2019/12/25192528586687.shtml",
    "datetime": "2019-12-25 19:25:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：取得《境外投资项目备案通知书》",
    "href": "http://stock.jrj.com.cn/2019/11/29172928469184.shtml",
    "datetime": "2019-11-29 17:29:18",
    "code": "002252"
  },
  {
    "title": "上海莱士：复牌的公告",
    "href": "http://stock.jrj.com.cn/2019/11/13213028395436.shtml",
    "datetime": "2019-11-13 21:30:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：重组过会 股票复牌",
    "href": "http://stock.jrj.com.cn/2019/11/13201928395255.shtml",
    "datetime": "2019-11-13 20:19:43",
    "code": "002252"
  },
  {
    "title": "上海莱士百亿重组上会 控制权曾引关注",
    "href": "http://stock.jrj.com.cn/2019/11/13012428390531.shtml",
    "datetime": "2019-11-13 01:24:34",
    "code": "002252"
  },
  {
    "title": "上海莱士：停牌公告",
    "href": "http://stock.jrj.com.cn/2019/11/12205028389913.shtml",
    "datetime": "2019-11-12 20:50:00",
    "code": "002252"
  },
  {
    "title": "上海莱士重组事项将上会 13日起停牌",
    "href": "http://stock.jrj.com.cn/2019/11/12174528388936.shtml",
    "datetime": "2019-11-12 17:45:18",
    "code": "002252"
  },
  {
    "title": "上海莱士：重组上会 13日起停牌",
    "href": "http://stock.jrj.com.cn/2019/11/12164828388638.shtml",
    "datetime": "2019-11-12 16:48:50",
    "code": "002252"
  },
  {
    "title": "证监会：上海莱士、东方能源11月13日重组上会",
    "href": "http://stock.jrj.com.cn/2019/11/07191928367382.shtml",
    "datetime": "2019-11-07 19:19:00",
    "code": "002252"
  },
  {
    "title": "上海莱士第三季度盈利1.93亿",
    "href": "http://stock.jrj.com.cn/2019/10/24110328292978.shtml",
    "datetime": "2019-10-24 11:03:40",
    "code": "002252"
  },
  {
    "title": "上海莱士：孙公司拟接受Biotest的授权在中国销售人血白蛋白注射液",
    "href": "http://stock.jrj.com.cn/2019/10/23220428290200.shtml",
    "datetime": "2019-10-23 22:04:24",
    "code": "002252"
  },
  {
    "title": "上海莱士前三季度净利6.06亿元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2019/10/23200028289818.shtml",
    "datetime": "2019-10-23 20:00:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：前三季度净利6.06亿元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2019/10/23182928289157.shtml",
    "datetime": "2019-10-23 18:29:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：前三季度净利6.06亿元 同比大幅扭亏",
    "href": "http://stock.jrj.com.cn/2019/10/23181428289017.shtml",
    "datetime": "2019-10-23 18:14:52",
    "code": "002252"
  },
  {
    "title": "重庆信托成功化解上海莱士股权质押风险 投资者利益得以保全",
    "href": "http://stock.jrj.com.cn/2019/10/15131128249386.shtml",
    "datetime": "2019-10-15 13:11:39",
    "code": "002252"
  },
  {
    "title": "上海莱士：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/15093028247875.shtml",
    "datetime": "2019-10-15 09:30:00",
    "code": "002252"
  },
  {
    "title": "上海莱士遭强平：被动减持7811万股 控股股东所有股份均被冻结",
    "href": "http://stock.jrj.com.cn/2019/10/13173128238937.shtml",
    "datetime": "2019-10-13 17:31:07",
    "code": "002252"
  },
  {
    "title": "上海莱士：发行股份购买GDS股权事项通过美国外国投资委员会审查",
    "href": "http://stock.jrj.com.cn/2019/10/08202428215052.shtml",
    "datetime": "2019-10-08 20:24:06",
    "code": "002252"
  },
  {
    "title": "上海莱士：购买GDS股权事项通过美国外国投资委员会审查",
    "href": "http://stock.jrj.com.cn/2019/10/08195028215006.shtml",
    "datetime": "2019-10-08 19:50:19",
    "code": "002252"
  },
  {
    "title": "上海莱士上半年净利增149% 资产负债率仅3%",
    "href": "http://stock.jrj.com.cn/2019/08/09054727950037.shtml",
    "datetime": "2019-08-09 05:47:02",
    "code": "002252"
  },
  {
    "title": "上海莱士2019年上半年盈利4.1亿 加强质量生产管理",
    "href": "http://stock.jrj.com.cn/2019/08/07212127944085.shtml",
    "datetime": "2019-08-07 21:21:50",
    "code": "002252"
  },
  {
    "title": "上海莱士：上半年净利4.13亿元 同比增长149%",
    "href": "http://stock.jrj.com.cn/2019/08/07202427943913.shtml",
    "datetime": "2019-08-07 20:24:42",
    "code": "002252"
  },
  {
    "title": "上海莱士：上半年净利4.13亿元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2019/08/07202327943909.shtml",
    "datetime": "2019-08-07 20:23:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：上半年实现净利润4.13亿元 同比增长148.75%",
    "href": "http://stock.jrj.com.cn/2019/08/07200927943853.shtml",
    "datetime": "2019-08-07 20:09:56",
    "code": "002252"
  },
  {
    "title": "[上海莱士]上海莱士荣登“2018年度中国医药工业百强榜”",
    "href": "http://stock.jrj.com.cn/2019/07/18000027876289.shtml",
    "datetime": "2019-07-18 00:00:00",
    "code": "002252"
  },
  {
    "title": "上海莱士业绩扭亏 血制品行业维持高景气度",
    "href": "http://stock.jrj.com.cn/2019/07/16195327848767.shtml",
    "datetime": "2019-07-16 19:53:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/13021027835113.shtml",
    "datetime": "2019-07-13 02:10:02",
    "code": "002252"
  },
  {
    "title": "上海莱士2019年上半年净利3.61亿-4.46亿 血液制品销售收入增长较大",
    "href": "http://stock.jrj.com.cn/2019/07/12214127834135.shtml",
    "datetime": "2019-07-12 21:41:53",
    "code": "002252"
  },
  {
    "title": "上海莱士预计上半年扭亏为盈 净利3.61亿元-4.46亿元",
    "href": "http://stock.jrj.com.cn/2019/07/12172127832682.shtml",
    "datetime": "2019-07-12 17:21:53",
    "code": "002252"
  },
  {
    "title": "上海莱士2019年上半年净利3.6亿~4.5亿 血液制品销售增长较大",
    "href": "http://stock.jrj.com.cn/2019/07/12170127832565.shtml",
    "datetime": "2019-07-12 17:01:38",
    "code": "002252"
  },
  {
    "title": "上海莱士：预计上半年扭亏为盈 净利3.61亿元-4.46亿元",
    "href": "http://stock.jrj.com.cn/2019/07/12164127832485.shtml",
    "datetime": "2019-07-12 16:41:00",
    "code": "002252"
  },
  {
    "title": "上海莱士预计上半年净利润同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2019/07/12163527832358.shtml",
    "datetime": "2019-07-12 16:35:12",
    "code": "002252"
  },
  {
    "title": "上海莱士：上半年预盈3.6亿-4.46亿元 同比大幅扭亏",
    "href": "http://stock.jrj.com.cn/2019/07/12163427832350.shtml",
    "datetime": "2019-07-12 16:34:46",
    "code": "002252"
  },
  {
    "title": "公告精选：上海莱士今后将不再进行证券投资；古越龙山部分产品提价",
    "href": "http://stock.jrj.com.cn/2019/05/24205427620516.shtml",
    "datetime": "2019-05-24 20:54:00",
    "code": "002252"
  },
  {
    "title": "公告精选：东阿阿胶拟7.5亿至15亿回购股份；上海莱士将不再进行证券投资",
    "href": "http://stock.jrj.com.cn/2019/05/24203127620449.shtml",
    "datetime": "2019-05-24 20:31:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：今后将不再进行证券投资",
    "href": "http://stock.jrj.com.cn/2019/05/24201627620422.shtml",
    "datetime": "2019-05-24 20:16:00",
    "code": "002252"
  },
  {
    "title": "上海莱士回复问询函：今后将不再进行证券投资",
    "href": "http://stock.jrj.com.cn/2019/05/24200927620375.shtml",
    "datetime": "2019-05-24 20:09:47",
    "code": "002252"
  },
  {
    "title": "上海莱士一季度净利2.19亿 扣非后净利润增长近两倍",
    "href": "http://stock.jrj.com.cn/2019/05/06170627530043.shtml",
    "datetime": "2019-05-06 17:06:36",
    "code": "002252"
  },
  {
    "title": "上海莱士一季度净利2.19亿 同比增长132% 现金流量净额为1.22亿元",
    "href": "http://stock.jrj.com.cn/2019/05/05080027522481.shtml",
    "datetime": "2019-05-05 08:00:18",
    "code": "002252"
  },
  {
    "title": "上海莱士去年营收18亿净利亏损15.2亿元 董事长陈杰薪酬364万元",
    "href": "http://stock.jrj.com.cn/2019/04/27113227495816.shtml",
    "datetime": "2019-04-27 11:32:07",
    "code": "002252"
  },
  {
    "title": "上海莱士：2018年度由盈转亏逾15亿元",
    "href": "http://stock.jrj.com.cn/2019/04/25222027484271.shtml",
    "datetime": "2019-04-25 22:20:34",
    "code": "002252"
  },
  {
    "title": "上海莱士：拟共同投资设立沂源县单采血浆站",
    "href": "http://stock.jrj.com.cn/2019/04/17210127417562.shtml",
    "datetime": "2019-04-17 21:01:55",
    "code": "002252"
  },
  {
    "title": "上海莱士拟与鲁教文化共同投资设立沂源县单采血浆站",
    "href": "http://stock.jrj.com.cn/2019/04/17204727417530.shtml",
    "datetime": "2019-04-17 20:47:20",
    "code": "002252"
  },
  {
    "title": "上海莱士：拟与鲁教文化共同投资设立沂源县单采血浆站",
    "href": "http://stock.jrj.com.cn/2019/04/17201827417426.shtml",
    "datetime": "2019-04-17 20:18:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：重大资产重组申请获得证监会受理",
    "href": "http://stock.jrj.com.cn/2019/04/01203927296669.shtml",
    "datetime": "2019-04-01 20:39:11",
    "code": "002252"
  },
  {
    "title": "上海莱士：一季度预盈1.72亿-2.32亿元",
    "href": "http://stock.jrj.com.cn/2019/03/26201527243265.shtml",
    "datetime": "2019-03-26 20:15:42",
    "code": "002252"
  },
  {
    "title": "上海莱士：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/03/26193027243057.shtml",
    "datetime": "2019-03-26 19:30:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：血液制品收入同比增长70%-80% 一季度预计扭亏为盈",
    "href": "http://stock.jrj.com.cn/2019/03/26191727243043.shtml",
    "datetime": "2019-03-26 19:17:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：一季度预计盈利1.7亿-2.3亿元",
    "href": "http://stock.jrj.com.cn/2019/03/26190727242981.shtml",
    "datetime": "2019-03-26 19:07:18",
    "code": "002252"
  },
  {
    "title": "上海莱士调整重大资产重组方案 交易目标股份下调至45%",
    "href": "http://stock.jrj.com.cn/2019/03/08113527135804.shtml",
    "datetime": "2019-03-08 11:35:32",
    "code": "002252"
  },
  {
    "title": "仅收购GDS 45%股权 交易作价降至132亿元 上海莱士8日复牌",
    "href": "http://stock.jrj.com.cn/2019/03/08002127133252.shtml",
    "datetime": "2019-03-08 00:21:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：关于披露发行股份购买资产草案暨公司股票复牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/03/07223027133053.shtml",
    "datetime": "2019-03-07 22:30:00",
    "code": "002252"
  },
  {
    "title": "上海莱士调整重大资产重组方案拟收购GDS 45%股权 3月8日复牌",
    "href": "http://stock.jrj.com.cn/2019/03/07220927133022.shtml",
    "datetime": "2019-03-07 22:09:47",
    "code": "002252"
  },
  {
    "title": "上海莱士：交易方案调整为仅收购GDS45%股权 明日复牌",
    "href": "http://stock.jrj.com.cn/2019/03/07220927133021.shtml",
    "datetime": "2019-03-07 22:09:33",
    "code": "002252"
  },
  {
    "title": "上海莱士：调整重大资产方案并复牌 拟仅收购GDS 45%股权",
    "href": "http://stock.jrj.com.cn/2019/03/07220927133023.shtml",
    "datetime": "2019-03-07 22:09:00",
    "code": "002252"
  },
  {
    "title": "[上海莱士]助力“东方美谷风雨彩”活动 上海莱士圆梦行动温暖贤城",
    "href": "http://stock.jrj.com.cn/2019/03/07000027133631.shtml",
    "datetime": "2019-03-07 00:00:00",
    "code": "002252"
  },
  {
    "title": "拟调整重大资产重组方案 上海莱士今起停牌",
    "href": "http://stock.jrj.com.cn/2019/03/04020427111275.shtml",
    "datetime": "2019-03-04 02:04:55",
    "code": "002252"
  },
  {
    "title": "上海莱士：关于拟调整重大资产重组方案的停牌公告",
    "href": "http://stock.jrj.com.cn/2019/03/03163027110631.shtml",
    "datetime": "2019-03-03 16:30:06",
    "code": "002252"
  },
  {
    "title": "上海莱士：拟调整重大资产重组方案 明起停牌",
    "href": "http://stock.jrj.com.cn/2019/03/03161627110612.shtml",
    "datetime": "2019-03-03 16:16:38",
    "code": "002252"
  },
  {
    "title": "上海莱士：拟调整重大资产重组方案 明日起停牌",
    "href": "http://stock.jrj.com.cn/2019/03/03161227110609.shtml",
    "datetime": "2019-03-03 16:12:40",
    "code": "002252"
  },
  {
    "title": "上海莱士业绩快报：2018年净利同比减275.72%",
    "href": "http://stock.jrj.com.cn/2019/02/27174527098010.shtml",
    "datetime": "2019-02-27 17:45:26",
    "code": "002252"
  },
  {
    "title": "上海莱士：2018年由盈转亏14.69亿元",
    "href": "http://stock.jrj.com.cn/2019/02/27174227098005.shtml",
    "datetime": "2019-02-27 17:42:10",
    "code": "002252"
  },
  {
    "title": "上海莱士10亿元投资莱士南方生物 股价翻身",
    "href": "http://stock.jrj.com.cn/2019/02/22003327072947.shtml",
    "datetime": "2019-02-22 00:33:12",
    "code": "002252"
  },
  {
    "title": "上海莱士调整莱士南方总部项目 总投资额降至10亿元",
    "href": "http://stock.jrj.com.cn/2019/02/21093527069860.shtml",
    "datetime": "2019-02-21 09:35:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：子公司拟投设莱士南方生物",
    "href": "http://stock.jrj.com.cn/2019/02/20204127067898.shtml",
    "datetime": "2019-02-20 20:41:00",
    "code": "002252"
  },
  {
    "title": "上海莱士延续强势 午后触及涨停",
    "href": "http://stock.jrj.com.cn/2019/02/19131227062120.shtml",
    "datetime": "2019-02-19 13:12:00",
    "code": "002252"
  },
  {
    "title": "超跌股表现抢眼 东方园林、上海莱士涨停",
    "href": "http://stock.jrj.com.cn/2019/02/15110327047213.shtml",
    "datetime": "2019-02-15 11:03:00",
    "code": "002252"
  },
  {
    "title": "超跌问题股表现抢眼 东方园林、上海莱士涨停",
    "href": "http://stock.jrj.com.cn/2019/02/15105227047135.shtml",
    "datetime": "2019-02-15 10:52:56",
    "code": "002252"
  },
  {
    "title": "上海莱士：副总经理徐俊拟增持300万至500万元",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/14075927042341.shtml",
    "datetime": "2019-02-14 07:59:58",
    "code": "002252"
  },
  {
    "title": "上海莱士：公司技术中心被认定为上海市级企业技术中心",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/14075927042340.shtml",
    "datetime": "2019-02-14 07:59:58",
    "code": "002252"
  },
  {
    "title": "上海莱士：董事副总拟出资300万元至500万元增持股份",
    "href": "http://stock.jrj.com.cn/2019/02/13170227038908.shtml",
    "datetime": "2019-02-13 17:02:39",
    "code": "002252"
  },
  {
    "title": "上海莱士：副总经理徐俊拟增持300万元至500万元",
    "href": "http://stock.jrj.com.cn/2019/02/13165927038871.shtml",
    "datetime": "2019-02-13 16:59:00",
    "code": "002252"
  },
  {
    "title": "上海莱士下调2018年全年净利润：资产重组中介费较多 财总年薪235万",
    "href": "http://stock.jrj.com.cn/2019/01/31111727007344.shtml",
    "datetime": "2019-01-31 11:17:37",
    "code": "002252"
  },
  {
    "title": "上海莱士：2018年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2019/01/30220027004020.shtml",
    "datetime": "2019-01-30 22:00:01",
    "code": "002252"
  },
  {
    "title": "上海莱士：下修业绩预期 2018年预亏12.79亿-15.3亿元",
    "href": "http://stock.jrj.com.cn/2019/01/30195727003416.shtml",
    "datetime": "2019-01-30 19:57:00",
    "code": "002252"
  },
  {
    "title": "[上海莱士]继往开莱 士耀全球 | 上海莱士30周年庆典暨2019年会",
    "href": "http://stock.jrj.com.cn/2019/01/29000027034174.shtml",
    "datetime": "2019-01-29 00:00:00",
    "code": "002252"
  },
  {
    "title": "行业转型升级 上海莱士等血液制品企业步入黄金发展期",
    "href": "http://stock.jrj.com.cn/2019/01/11133826890114.shtml",
    "datetime": "2019-01-11 13:38:09",
    "code": "002252"
  },
  {
    "title": "上海莱士：控股股东一致行动人存被动减持风险",
    "href": "http://stock.jrj.com.cn/2019/01/08211726875114.shtml",
    "datetime": "2019-01-08 21:17:07",
    "code": "002252"
  },
  {
    "title": "上海莱士被动减持分散实施 股东控股地位不受影响",
    "href": "http://stock.jrj.com.cn/2018/12/26121926804905.shtml",
    "datetime": "2018-12-26 12:19:52",
    "code": "002252"
  },
  {
    "title": "资金流向：尾盘主力重回净流入 上海莱士净流入居首",
    "href": "http://stock.jrj.com.cn/2018/12/26065326803195.shtml",
    "datetime": "2018-12-26 06:53:35",
    "code": "002252"
  },
  {
    "title": "上海莱士控股股东一致行动人股票质押违约 或被动减持",
    "href": "http://stock.jrj.com.cn/2018/12/25195426801580.shtml",
    "datetime": "2018-12-25 19:54:30",
    "code": "002252"
  },
  {
    "title": "融贯中西合作共赢 上海莱士稳步推进391亿跨境并购",
    "href": "http://stock.jrj.com.cn/invest/2018/12/25190626801424.shtml",
    "datetime": "2018-12-25 19:06:49",
    "code": "002252"
  },
  {
    "title": "上海莱士再度跌停开盘 封单逾62万手",
    "href": "http://stock.jrj.com.cn/2018/12/24092626791189.shtml",
    "datetime": "2018-12-24 09:26:11",
    "code": "002252"
  },
  {
    "title": "10跌停后开板 21亿资金搏杀上海莱士",
    "href": "http://stock.jrj.com.cn/2018/12/22054626782350.shtml",
    "datetime": "2018-12-22 05:46:19",
    "code": "002252"
  },
  {
    "title": "天量资金突袭 上海莱士10跌停后首次开板",
    "href": "http://stock.jrj.com.cn/2018/12/21221026781429.shtml",
    "datetime": "2018-12-21 22:10:21",
    "code": "002252"
  },
  {
    "title": "上海莱士打开跌停 低开9.25%集合竞价成交近8亿元",
    "href": "http://stock.jrj.com.cn/2018/12/21092626777034.shtml",
    "datetime": "2018-12-21 09:26:20",
    "code": "002252"
  },
  {
    "title": "股价10连跌停 上海莱士近400亿元收购案能否落地",
    "href": "http://stock.jrj.com.cn/2018/12/21024826775386.shtml",
    "datetime": "2018-12-21 02:48:46",
    "code": "002252"
  },
  {
    "title": "血液制品毛利率超60% 上海莱士多措并举夯实主业",
    "href": "http://stock.jrj.com.cn/2018/12/20093726770068.shtml",
    "datetime": "2018-12-20 09:37:04",
    "code": "002252"
  },
  {
    "title": "上海莱士复牌连续10日跌停 总市值蒸发630亿元",
    "href": "http://stock.jrj.com.cn/2018/12/20092526769989.shtml",
    "datetime": "2018-12-20 09:25:21",
    "code": "002252"
  },
  {
    "title": "早间公告：李东生追加对TCL集团的增持计划 上海莱士两股东昨遭被动减持",
    "href": "http://stock.jrj.com.cn/2018/12/20080126769568.shtml",
    "datetime": "2018-12-20 08:01:00",
    "code": "002252"
  },
  {
    "title": "上海莱士炒股巨亏14亿 9天暴跌61%市值蒸发600亿",
    "href": "http://stock.jrj.com.cn/2018/12/20064526768282.shtml",
    "datetime": "2018-12-20 06:45:35",
    "code": "002252"
  },
  {
    "title": "上海莱士：控股股东或被动减持1.8%股份",
    "href": "http://stock.jrj.com.cn/2018/12/19210826766952.shtml",
    "datetime": "2018-12-19 21:08:00",
    "code": "002252"
  },
  {
    "title": "“股神”炒股巨亏14亿:9天暴跌61% 市值没了600亿",
    "href": "http://stock.jrj.com.cn/2018/12/19202626766764.shtml",
    "datetime": "2018-12-19 20:26:53",
    "code": "002252"
  },
  {
    "title": "上海莱士控股股东莱士中国存在可能被动减持股票风险",
    "href": "http://stock.jrj.com.cn/2018/12/19202326766759.shtml",
    "datetime": "2018-12-19 20:23:21",
    "code": "002252"
  },
  {
    "title": "上海莱士391亿并购海外标的 覆盖全球销售市场",
    "href": "http://stock.jrj.com.cn/2018/12/19111226764194.shtml",
    "datetime": "2018-12-19 11:12:00",
    "code": "002252"
  },
  {
    "title": "上海莱士复牌连续9日跌停 总市值蒸发近600亿元",
    "href": "http://stock.jrj.com.cn/2018/12/19092526763642.shtml",
    "datetime": "2018-12-19 09:25:18",
    "code": "002252"
  },
  {
    "title": "千亿龙头公司跌落神坛：8个交易日500亿市值蒸发",
    "href": "http://stock.jrj.com.cn/2018/12/18220026761590.shtml",
    "datetime": "2018-12-18 22:00:12",
    "code": "002252"
  },
  {
    "title": "上海莱士携国际血制品龙头 纵横联合协同发展",
    "href": "http://stock.jrj.com.cn/2018/12/18170226760307.shtml",
    "datetime": "2018-12-18 17:02:56",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌连续8日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/18092526758164.shtml",
    "datetime": "2018-12-18 09:25:27",
    "code": "002252"
  },
  {
    "title": "[天眼]上海莱士390亿重组预案收问询:明确募资必要性",
    "href": "http://stock.jrj.com.cn/2018/12/17153926754427.shtml",
    "datetime": "2018-12-17 15:39:09",
    "code": "002252"
  },
  {
    "title": "祭出391亿重组预案无力回天 上海莱士复牌连续6跌停",
    "href": "http://stock.jrj.com.cn/2018/12/17131926753664.shtml",
    "datetime": "2018-12-17 13:19:26",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌连续7日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/17092626752467.shtml",
    "datetime": "2018-12-17 09:26:44",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌连续6日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/14092926739708.shtml",
    "datetime": "2018-12-14 09:29:31",
    "code": "002252"
  },
  {
    "title": "上海莱士5跌停市值蒸发逾700亿 2.3亿股存被动减持风险",
    "href": "http://stock.jrj.com.cn/2018/12/13161426735296.shtml",
    "datetime": "2018-12-13 16:14:00",
    "code": "002252"
  },
  {
    "title": "国际血制品巨头基立福抓住机遇 拟巨资战略入股上海莱士",
    "href": "http://stock.jrj.com.cn/2018/12/13103926631643.shtml",
    "datetime": "2018-12-13 10:39:41",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌连续5日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/13092926598043.shtml",
    "datetime": "2018-12-13 09:29:51",
    "code": "002252"
  },
  {
    "title": "上海莱士控股股东持股存被动减持风险",
    "href": "http://stock.jrj.com.cn/2018/12/13012926427856.shtml",
    "datetime": "2018-12-13 01:29:13",
    "code": "002252"
  },
  {
    "title": "股票质押违约 上海莱士控股股东持股存被动减持风险",
    "href": "http://stock.jrj.com.cn/2018/12/12202426325119.shtml",
    "datetime": "2018-12-12 20:24:48",
    "code": "002252"
  },
  {
    "title": "上海莱士：并购增厚主业 商誉暂未减值",
    "href": "http://stock.jrj.com.cn/2018/12/12103625981515.shtml",
    "datetime": "2018-12-12 10:36:34",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌连续4日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/12093325941125.shtml",
    "datetime": "2018-12-12 09:33:31",
    "code": "002252"
  },
  {
    "title": "两大股东质押违约 上海莱士2.3亿股或触发被动减持",
    "href": "http://stock.jrj.com.cn/2018/12/12034925726195.shtml",
    "datetime": "2018-12-12 03:49:32",
    "code": "002252"
  },
  {
    "title": "上海莱士控股股东所持部分股票存在被动减持风险",
    "href": "http://stock.jrj.com.cn/2018/12/11215225545395.shtml",
    "datetime": "2018-12-11 21:52:51",
    "code": "002252"
  },
  {
    "title": "两大控股股东同时质押违约 上海莱士2.3亿股或触发被动减持",
    "href": "http://stock.jrj.com.cn/2018/12/11214225545307.shtml",
    "datetime": "2018-12-11 21:42:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：控股股东所持部分股票存在被动减持风险",
    "href": "http://stock.jrj.com.cn/2018/12/11200325542529.shtml",
    "datetime": "2018-12-11 20:03:00",
    "code": "002252"
  },
  {
    "title": "上海莱士拓展体外诊断领域 市场规模达数千亿",
    "href": "http://stock.jrj.com.cn/2018/12/11100825524045.shtml",
    "datetime": "2018-12-11 10:08:42",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌连续3日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/11092525522610.shtml",
    "datetime": "2018-12-11 09:25:57",
    "code": "002252"
  },
  {
    "title": "机构龙虎榜:上海莱士继续遭机构撬买 1机构买1502万",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/10205125501454.shtml",
    "datetime": "2018-12-10 20:51:15",
    "code": "002252"
  },
  {
    "title": "跨境并购回暖 上海莱士391亿外资并购引期待",
    "href": "http://stock.jrj.com.cn/2018/12/10105225491959.shtml",
    "datetime": "2018-12-10 10:52:43",
    "code": "002252"
  },
  {
    "title": "上海莱士复牌一字跌停 前海开源吴国清为何心慌？",
    "href": "http://stock.jrj.com.cn/2018/12/10094625490776.shtml",
    "datetime": "2018-12-10 09:46:10",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌连续两日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/10093725490609.shtml",
    "datetime": "2018-12-10 09:37:39",
    "code": "002252"
  },
  {
    "title": "停牌9月难逃跌停命运 上海莱士天价并购遭用脚投票",
    "href": "http://stock.jrj.com.cn/2018/12/08071525475669.shtml",
    "datetime": "2018-12-08 07:15:24",
    "code": "002252"
  },
  {
    "title": "上海莱士天价并购遭遇“用脚投票”",
    "href": "http://stock.jrj.com.cn/2018/12/07223125473546.shtml",
    "datetime": "2018-12-07 22:31:45",
    "code": "002252"
  },
  {
    "title": "龙虎榜:炒股亏9亿的上海莱士 一个跌停大股东就爆仓",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/07220625473409.shtml",
    "datetime": "2018-12-07 22:06:42",
    "code": "002252"
  },
  {
    "title": "上海莱士：控股股东存在被动减持公司股票风险",
    "href": "http://stock.jrj.com.cn/2018/12/07204525473154.shtml",
    "datetime": "2018-12-07 20:45:00",
    "code": "002252"
  },
  {
    "title": "上海莱士控股股东科瑞天诚及其一致行动人拟被动减持",
    "href": "http://stock.jrj.com.cn/2018/12/07204325473123.shtml",
    "datetime": "2018-12-07 20:43:20",
    "code": "002252"
  },
  {
    "title": "炒股亏损业绩凉凉 上海莱士391亿并购难阻复牌百亿市值蒸发",
    "href": "http://stock.jrj.com.cn/2018/12/07194125472921.shtml",
    "datetime": "2018-12-07 19:41:46",
    "code": "002252"
  },
  {
    "title": "上海莱士高估值“控盘”硬爆破 控股股东质押29亿股",
    "href": "http://stock.jrj.com.cn/2018/12/07114325470547.shtml",
    "datetime": "2018-12-07 11:43:00",
    "code": "002252"
  },
  {
    "title": "上海莱士复牌首日跌停",
    "href": "http://stock.jrj.com.cn/2018/12/07093325469840.shtml",
    "datetime": "2018-12-07 09:33:00",
    "code": "002252"
  },
  {
    "title": "上海莱士拟391亿并购血制品龙头 复牌跌停封单近30亿",
    "href": "http://stock.jrj.com.cn/2018/12/07092525469777.shtml",
    "datetime": "2018-12-07 09:25:28",
    "code": "002252"
  },
  {
    "title": "炒股巨亏9亿元！停牌长达9个月！上海莱士7日复牌！",
    "href": "http://stock.jrj.com.cn/2018/12/07075125469209.shtml",
    "datetime": "2018-12-07 07:51:15",
    "code": "002252"
  },
  {
    "title": "391亿元！上海莱士巨额并购案出炉 明日复牌",
    "href": "http://stock.jrj.com.cn/2018/12/06235025465020.shtml",
    "datetime": "2018-12-06 23:50:00",
    "code": "002252"
  },
  {
    "title": "上海莱士：拟收购GDS股权和天诚德国100%股权 布局全球重要血液制品市场",
    "href": "http://stock.jrj.com.cn/2018/12/06220525464739.shtml",
    "datetime": "2018-12-06 22:05:00",
    "code": "002252"
  },
  {
    "title": "上海莱士拟收购GDS股权和天诚德国100%股权 7日复牌",
    "href": "http://stock.jrj.com.cn/2018/12/06215625464641.shtml",
    "datetime": "2018-12-06 21:56:23",
    "code": "002252"
  },
  {
    "title": "上海莱士证券投资究竟亏了多少钱？",
    "href": "http://stock.jrj.com.cn/2018/12/05095325452129.shtml",
    "datetime": "2018-12-05 09:53:23",
    "code": "002252"
  },
  {
    "title": "[上海莱士]上海莱士协办血液制品行业峰会 创新实践引领行业趋势",
    "href": "http://stock.jrj.com.cn/2018/12/03000025439628.shtml",
    "datetime": "2018-12-03 00:00:00",
    "code": "002252"
  },
  {
    "title": "上海莱士并购血液制品巨头弥补技术短板",
    "href": "http://stock.jrj.com.cn/2018/11/26010925404909.shtml",
    "datetime": "2018-11-26 01:09:25",
    "code": "002252"
  },
  {
    "title": "上海莱士抛“天价”海外并购计划",
    "href": "http://stock.jrj.com.cn/2018/11/26010825404908.shtml",
    "datetime": "2018-11-26 01:08:50",
    "code": "002252"
  },
  {
    "title": "上海莱士拟豪掷400亿元收购国外两公司",
    "href": "http://stock.jrj.com.cn/2018/11/24090225401738.shtml",
    "datetime": "2018-11-24 09:02:37",
    "code": "002252"
  },
  {
    "title": "【智汇评】最新最全庄股名单！大庄股上海莱士！",
    "href": "http://stock.jrj.com.cn/2018/11/23192825399090.shtml",
    "datetime": "2018-11-23 19:28:36",
    "code": "002252"
  },
  {
    "title": "停牌9个月后宣布400亿并购！或成国内最大医药并购案",
    "href": "http://stock.jrj.com.cn/2018/11/23082225396130.shtml",
    "datetime": "2018-11-23 08:22:01",
    "code": "002252"
  },
  {
    "title": "上海莱士拟近400亿元跨境并购两家血制品巨头",
    "href": "http://stock.jrj.com.cn/2018/11/23045925395321.shtml",
    "datetime": "2018-11-23 04:59:19",
    "code": "002252"
  },
  {
    "title": "上海莱士拟启动近400亿跨境并购 加码血液产业链布局",
    "href": "http://stock.jrj.com.cn/2018/11/23024225395025.shtml",
    "datetime": "2018-11-23 02:42:29",
    "code": "002252"
  },
  {
    "title": "公告精选：日科化学获鲁民投基金举牌；上海莱士拟近400亿元并购天诚德国和GDS",
    "href": "http://stock.jrj.com.cn/2018/11/22211125393597.shtml",
    "datetime": "2018-11-22 21:11:00",
    "code": "002252"
  },
  {
    "title": "上海莱士近400亿元拟跨境并购两大血制品龙头",
    "href": "http://stock.jrj.com.cn/2018/11/22195425393358.shtml",
    "datetime": "2018-11-22 19:54:09",
    "code": "002252"
  },
  {
    "title": "中国史上最大医药并购:上海莱士拟近400亿并购公司",
    "href": "http://stock.jrj.com.cn/2018/11/22195225393356.shtml",
    "datetime": "2018-11-22 19:52:28",
    "code": "002252"
  },
  {
    "title": "上海莱士拟近400亿并购海外血制品产业链公司",
    "href": "http://stock.jrj.com.cn/2018/11/22192425393300.shtml",
    "datetime": "2018-11-22 19:24:32",
    "code": "002252"
  },
  {
    "title": "上海莱士：拟近400亿元并购天诚德国和GDS",
    "href": "http://stock.jrj.com.cn/2018/11/22183125393092.shtml",
    "datetime": "2018-11-22 18:31:00",
    "code": "002252"
  },
  {
    "title": "上海莱士拟近400亿元并购两公司",
    "href": "http://stock.jrj.com.cn/2018/11/22182625393053.shtml",
    "datetime": "2018-11-22 18:26:26",
    "code": "002252"
  },
  {
    "title": "[上海莱士]湖南省卫生健康委员会领导及专家团一行至公司参观访问",
    "href": "http://stock.jrj.com.cn/2018/11/14000025345294.shtml",
    "datetime": "2018-11-14 00:00:00",
    "code": "002252"
  },
  {
    "title": "769家公司全年业绩预喜 部分公司预计亏损",
    "href": "http://stock.jrj.com.cn/2018/11/02024225294862.shtml",
    "datetime": "2018-11-02 02:42:39",
    "code": "002252"
  }
]